You have 9 free searches left this month | for more free features.

Illuminare-1

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in Worldwide (VH3739937, Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +18 more
Sep 22, 2023

Type 1 Diabetes Trial in Pamplona (Diactive-1 application)

Recruiting
  • Type 1 Diabetes
  • Diactive-1 application
  • Pamplona, Navarra, Spain
  • +1 more
Sep 20, 2023

Breast Cancer, Oral Cancer Trial in Mumbai (Cannabis capsules)

Active, not recruiting
  • Breast Cancer
  • Oral Cancer
  • Cannabis capsules
  • Mumbai, Maharashtra, India
  • +1 more
Jul 22, 2023

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Advanced Solid Tumor Trial in São Paulo, Santo André (IMX-110 combined with Tislelizumab)

Recruiting
  • Advanced Solid Tumor
  • IMX-110 combined with Tislelizumab
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Apr 28, 2023

Healthy Trial in Berlin, Hamburg (LY06006 (Denosumab Biosimilar), US-Prolia (Denosumab), EU-Prolia)

Completed
  • Healthy
  • LY06006 (Denosumab Biosimilar)
  • +2 more
  • Berlin, Germany
  • +1 more
Oct 18, 2023

Hepatorenal Syndrome at Methodist Dallas Medical Center

Recruiting
  • Hepatorenal Syndrome
  • Hepatorenal Syndrome outcome in Patients at Methodist Health systems
  • Dallas, Texas
    Liver Institute of Methodist Dallas Medical Center
Oct 18, 2023

Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT

Recruiting
  • Olfactory Impairment
    • Nancy, France
    • +1 more
    Oct 8, 2023

    Ulcerative Colitis Trial in Manchester (SOR102, Placebo)

    Recruiting
    • Ulcerative Colitis
    • Manchester, United Kingdom
      MAC Clinical Research
    Oct 6, 2023

    Prostate Cancer Trial ([177Lu]Lu-PSMA I&T, Stereotactic Radiotherapy)

    Not yet recruiting
    • Prostate Cancer
    • [177Lu]Lu-PSMA I&T
    • Stereotactic Radiotherapy
    • (no location specified)
    May 30, 2023

    Cardiovascular Biomarkers in Peripheral Artery Disease.

    Active, not recruiting
    • Peripheral Artery Disease
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Feb 24, 2023

      Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • carboplatin chemotherapy
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Nov 3, 2023

      Developmental Endothelial Locus-1, Platelet Count, and Soluble

      Not yet recruiting
      • Overweight and Obesity
      • Platelet count
      • +2 more
      • Aswan, Egypt
        Aswan University Hospital
      May 17, 2023

      Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)

      Not yet recruiting
      • Alcohol Use Disorder
      • Prazosin + cyproheptadine
      • KT110
      • (no location specified)
      Nov 27, 2023

      Joint Pain Trial in Mumbai, Nashik, Panvel (E-PR-01 (Low dose), E-PR-01 (High Dose), Placebo)

      Not yet recruiting
      • Joint Pain
      • E-PR-01 (Low dose)
      • +2 more
      • Mumbai, Maharashtra, India
      • +3 more
      Apr 24, 2023

      Resuscitative Thoracotomy Practices

      Enrolling by invitation
      • Resuscitative Thoracotomy Practices
      • Resuscitative thoracotomies
      • Dallas, Texas
        Methodist Dallas Medical Center
      Jul 6, 2023

      Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

      Not yet recruiting
      • Advanced Solid Tumors
      • LCB84
      • Anti-PD-1 monoclonal antibody
      • Los Angeles, California
      • +6 more
      Jul 4, 2023

      Infectious Diseases Trial in Taichung (cefoperazone sodium and sulbactam sodium)

      Active, not recruiting
      • Infectious Diseases
      • cefoperazone sodium and sulbactam sodium
      • Taichung, Taiwan
        Taichung Veterans General Hospital
      Jan 29, 2023

      Non Small Cell Lung Cancer Trial in China (TQB2450 injection + Chemotherapy, TQB2450 injection + Anlotinib Hydrochloride

      Recruiting
      • Non Small Cell Lung Cancer
      • TQB2450 injection + Chemotherapy
      • TQB2450 injection + Anlotinib Hydrochloride Capsule
      • Beijing, Beijing, China
      • +9 more
      Jun 27, 2023

      Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

      Recruiting
      • Multiple Myeloma
      • ATAC-seq and ChIP-seq
      • Roma, Italy
      • +1 more
      May 4, 2023

      Type 1 Diabetes Trial in Kuwait City (Morning exercise, Afternoon exercise, Habitual physical activity levels)

      Not yet recruiting
      • Type 1 Diabetes
      • Morning exercise
      • +2 more
      • Kuwait City, Kuwait
        Dasman Diabetes Institute
      May 22, 2023

      Osteoarthritis, Knee, Osteoarthritis, Knee Osteoarthritis Trial in Russian Federation (undenaturated collagen type II,

      Completed
      • Osteoarthritis, Knee
      • +6 more
      • undenaturated collagen type II, methylsulfonylmethane, boswellia serrata, vitamin D3 (cholecalciferol), vitamin C (ARTNEO)
      • Placebo
      • Kazan, Russian Federation
      • +11 more
      Aug 3, 2023

      Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Aldesleukin
      • +12 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Aug 9, 2023

      Anxiety, Type 1 Diabetes, Quality of Life Trial in Tampa (Mindfulness training)

      Recruiting
      • Anxiety
      • +2 more
      • Mindfulness training
      • Tampa, Florida
        University of South Florida College of Nursing
      Nov 14, 2023